Bulletin
Investor Alert

Abbott Laboratories

NYS: ABT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 7, 2021, 7:23 p.m.

ABT
/zigman2/quotes/203724446/composite

$

118.80

Change

-0.15 -0.13%

Volume

Volume 214,510

Quotes are delayed by 20 min

/zigman2/quotes/203724446/composite

Previous close

$ 118.79

$ 118.95

Change

+0.16 +0.13%

Day low

Day high

$118.76

$120.42

Open

52 week low

52 week high

$86.16

$128.54

Open

Annual Financials for Abbott Laboratories

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 20.85B27.39B30.58B31.9B34.61B
Cost of Goods Sold (COGS) incl. D&A 9.61B14.32B14.76B15.21B17.23B
COGS excluding D&A 8.26B11.3B11.48B12.2B13.9B
Depreciation & Amortization Expense 1.35B3.02B3.28B3.01B3.33B
Depreciation 803M1.05B1.1B1.08B1.2B
Amortization of Intangibles 550M1.98B2.18B1.94B2.13B
Gross Income 11.24B13.07B15.82B16.69B17.38B
20162017201820192020 5-year trend
SG&A Expense 8B11.09B11.98B12.1B12.09B
Research & Development 1.36B2.13B2.29B2.41B2.42B
Other SG&A 6.64B8.96B9.69B9.69B9.67B
Other Operating Expense -----
Unusual Expense 112M360M247M201M151M
EBIT after Unusual Expense 3.14B(360M)3.6B4.39B5.14B
Non Operating Income/Expense (1.52B)1.38B(100M)411M490M
Non-Operating Interest Income 99M124M105M94M46M
Equity in Affiliates (Pretax) -----
Interest Expense 304M880M729M818M708M
Gross Interest Expense 326M880M729M818M708M
Interest Capitalized 22M----
Pretax Income 1.41B2.23B2.87B4.08B4.97B
Income Tax 350M1.88B539M390M497M
Income Tax - Current Domestic 71M2.26B(812M)291M39M
Income Tax - Current Foreign 406M508M606M590M566M
Income Tax - Deferred Domestic (147M)(679M)832M(305M)(18M)
Income Tax - Deferred Foreign 20M(211M)(87M)(186M)(90M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) (7M)(9M)(15M)(21M)(22M)
Consolidated Net Income 1.06B344M2.32B3.67B4.45B
Minority Interest Expense -----
Net Income 1.06B344M2.32B3.67B4.45B
Extraordinaries & Discontinued Operations 337M124M34M-24M
Extra Items & Gain/Loss Sale Of Assets 16M----
Cumulative Effect - Accounting Chg -----
Discontinued Operations 321M124M34M-24M
Net Income After Extraordinaries 1.39B468M2.35B3.67B4.47B
Preferred Dividends -----
Net Income Available to Common 1.38B468M2.35B3.67B4.47B
EPS (Basic) 0.930.271.342.072.52
Basic Shares Outstanding 1.48B1.74B1.76B1.77B1.77B
EPS (Diluted) 0.930.271.332.062.50
Diluted Shares Outstanding 1.48B1.75B1.77B1.78B1.79B
EBITDA 4.6B4.99B7.12B7.61B8.62B
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.